Peter J. DeMaria, MD is a medical oncologist with a focus on early phase drug development at NEXT Oncology.   Dr. DeMaria is a graduate of the NCI-FDA Interagency Oncology Task Force, a joint fellowship program with the National Cancer Institute (NCI), National Institutes of Health (NIH), and the U.S. Food and Drug Administration (FDA). Dr. DeMaria completed an NCI-sponsored …

Dr. Michael Song is a medical oncologist and hematologist, as well as a board certified internal medicine physician. He has over 22 years of experience in cancer patient care and cancer research. He is a compassionate physician who recognizes the critical importance of physician-patient partnership in cancer care. He also recognizes the value of patient and family empowerment through knowledge …

Medical Oncologist and Clinical Investigator Dr. Rodriguez is a Phase 1 clinical investigator at NEXT Oncology in San Antonio, Texas. He is board-certified in internal medicine, hematology, and medical oncology. He leads multiple clinical trials at NEXT and is thrilled to offer clinical trial options for the diverse community of San Antonio. One of his goals is to expand patient …

Dr. David Sommerhalder specializes in and is board certified in medical oncology and hematology and is also board certified in internal medicine. He works at NEXT Oncology San Antonio as an investigator on numerous clinical trials, where he helps to find additional treatment options for patients who otherwise may be out of options. He does this with the ultimate goal …

Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT Oncology. He is dedicated to the development of new anticancer agents — including clinical trials and therapies — for patients looking for their next option now that their current cancer therapy is no longer working to their benefit. Dr. Tolcher is proud that the NEXT Oncology team scours the …